Licence and good manufacturing practice
A state manufacturing licence, with the site meeting Schedule M good manufacturing practice under the Drugs and Cosmetics Rules, 1945.
Acts and rules on CDSCOStock audit glossary · Pharmaceuticals
noun · abbreviated API; often called the active ingredient or bulk drug
An active pharmaceutical ingredient (API) is the substance in a medicine that produces its intended therapeutic effect. The other materials in the dose, the excipients, carry, bind, preserve or flavour it. In a pharmaceutical store the API is usually the costliest input and the most tightly controlled, and it is tracked batch by batch from receipt to the finished product it went into.
Meaning
Only a small part of a tablet or vial does the therapeutic work. The rest of the mass gives the dose its shape, stability and taste. That small active part usually carries most of the material cost of a batch and nearly all of the regulatory attention, so it is bought against a specification, stored in set conditions and issued only against a batch record.
For a stock count this changes what “present” means. A drum of API on the rack can be used only once quality control has released it and while its retest date has not passed. Material still awaiting a quality decision, or overdue for retest, looks exactly like released stock, so the count records batch and release status next to the weight.
Who holds it
The same drum means different things to different holders.
In practice
Against a purchase specification and the supplier’s certificate of analysis, booked as quarantined at once.
Against the specification. The supplier’s certificate supports the check; it does not replace it.
Only released material can be issued, however urgent the production plan.
In the set conditions, with the batch number staying with the material through every move.
Use is recorded on the batch record of the product made, and each API batch is reconciled to what is left.
Worked example
Sample figures for one batch.
| Input | Quantity and rate | Value (INR) |
|---|---|---|
| API | 42 kg at 78,000 per kg | 32,76,000 |
| Excipients | 1,850 kg at 240 per kg | 4,44,000 |
| Packaging | 60,000 units at 9 each | 5,40,000 |
| Batch total | Three inputs | 42,60,000 |
The API is just over 2 kg in every 100 kg of material in the batch, yet about three-quarters of its value. A counting error of one-twentieth on the excipients (92.5 kg) moves the batch value by 22,200; the same one-twentieth on the API (2.1 kg) moves it by 1,63,800.
That is why the API is weighed on calibrated scales, reconciled batch by batch and kept under separate access, while excipients are checked more lightly. The smallest quantity in the table takes the most attention.
Framework
Making an active ingredient is a licensed activity. Manufacture needs a licence from the state licensing authority, and the site must meet Schedule M good manufacturing practice under the Drugs and Cosmetics Rules, 1945. Schedule M also keeps incoming materials in quarantine until quality control has tested and released them, which is why release status is part of every API count.
A state manufacturing licence, with the site meeting Schedule M good manufacturing practice under the Drugs and Cosmetics Rules, 1945.
Acts and rules on CDSCOUnder Schedule M, incoming materials stay in quarantine until tested and released by quality control.
Acts and rules on CDSCORevised by G.S.R. 922(E) of 28 December 2023; the extended compliance date for smaller manufacturers ran to 31 December 2025.
CDSCOWatch out
Quantity is the least of what has to be right.
Material still awaiting a quality decision is shown as available.
The total is known but not the split between batches.
The material looks ordinary but cannot be used until retested.
A recorded temperature breach can make the material unusable.
Losses that a batch-by-batch check would show stay hidden.
The specification may call for in-house testing as well.
Question
An API is made in a manufacturing plant, usually by chemical synthesis or by a biological process such as fermentation, and is then purified and tested against its specification before quality control releases it. In India, manufacturing active ingredients needs a licence from the state licensing authority, and the site must meet Schedule M good manufacturing practice under the Drugs and Cosmetics Rules, 1945.
Patron Accounting LLP. Statements on the Drugs and Cosmetics Rules and Schedule M on this page signed off by CA Sundram Gupta: 23 October 2026
Sources: Drugs and Cosmetics Act, 1940 and Rules, 1945, Schedule M as revised by G.S.R. 922(E) of 28 December 2023 (CDSCO). General information, not professional advice; check the current position for your site before acting.
Need help with active pharmaceutical ingredients? See our stock audit for pharmaceutical manufacturing service. A pharmaceutical stock audit counts API by batch and release status.